Pharmedic Pharmaceutical Medicinal JSC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000PMC3
VND
140,800.00
30200 (27.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

VND Million (Small Cap)

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.30

stock-summary
Return on Equity

35.58%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
162,124 Million
(Quarterly Results - Dec 2025)
Net Profit:
17,862 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
24.27%
0%
24.27%
6 Months
6.67%
0%
6.67%
1 Year
61.84%
0%
61.84%
2 Years
104.95%
0%
104.95%
3 Years
114.63%
0%
114.63%
4 Years
116.28%
0%
116.28%
5 Years
166.67%
0%
166.67%

Pharmedic Pharmaceutical Medicinal JSC for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
2.64%
EBIT Growth (5y)
2.48%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.56
Sales to Capital Employed (avg)
1.53
Tax Ratio
20.12%
Dividend Payout Ratio
273.90%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
79.55%
ROE (avg)
21.70%

Valuation key factors

Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
-0.77
EV to EBITDA
-0.70
EV to Capital Employed
-0.42
EV to Sales
-0.15
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
33.44%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 28.14% vs -4.34% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -7.84% vs -13.34% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "162,124.20",
          "val2": "126,519.10",
          "chgp": "28.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "21,426.10",
          "val2": "26,411.70",
          "chgp": "-18.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "259.70",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "17,862.10",
          "val2": "19,380.60",
          "chgp": "-7.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "132.20%",
          "val2": "186.30%",
          "chgp": "-5.41%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 9.71% vs 2.68% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 40.70% vs -4.11% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "546,566.50",
          "val2": "498,185.00",
          "chgp": "9.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "109,908.30",
          "val2": "101,916.30",
          "chgp": "7.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "302.50",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "82,304.90",
          "val2": "58,497.20",
          "chgp": "40.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "179.10%",
          "val2": "181.60%",
          "chgp": "-0.25%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
162,124.20
126,519.10
28.14%
Operating Profit (PBDIT) excl Other Income
21,426.10
26,411.70
-18.88%
Interest
0.00
259.70
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
17,862.10
19,380.60
-7.84%
Operating Profit Margin (Excl OI)
132.20%
186.30%
-5.41%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 28.14% vs -4.34% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -7.84% vs -13.34% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
546,566.50
498,185.00
9.71%
Operating Profit (PBDIT) excl Other Income
109,908.30
101,916.30
7.84%
Interest
302.50
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
82,304.90
58,497.20
40.70%
Operating Profit Margin (Excl OI)
179.10%
181.60%
-0.25%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 9.71% vs 2.68% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 40.70% vs -4.11% in Dec 2024

stock-summaryCompany CV
About Pharmedic Pharmaceutical Medicinal JSC stock-summary
stock-summary
Pharmedic Pharmaceutical Medicinal JSC
Pharmaceuticals & Biotechnology
Pharmedic Pharmaceutical Medicinal Joint Stock Company is a Vietnam-based company principally engaged in the manufacturing and distributing of pharmaceutical products, medicines, cosmetic and other products used in the healthcare sector. In addition, the Company is involved in the provision of printing services of plastic, paper and aluminum packagings. Moreover, it is active in the manufacture and trading of chemical products, such as pesticides and detergents for household and medical usage. During the year ended December 31, 2012, 97.24% of the Company's total revenue came from the sale of finished products. As of December 31, 2012, the Company was an affiliate of Saigon Pharmaceutical Company Limited (SAPHARCO), and it had a factory in Ho Chi Minh City, Vietnam.
Company Coordinates stock-summary
Company Details
367 Nguyen Trai, Phuong Nguyen Cu Trinh, Quan 1 HO CHI MINH None : None
stock-summary
Tel: 84 8 38375300
stock-summary
Registrar Details